BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MyoScience Inc. Appoints Quentin Manley as Vice President


12/14/2011 3:16:43 PM

Redwood City, CA - (December 14, 2011) – myoscience announces the addition of Quentin Manley as Vice President of Global Sales and Marketing to the management team. He will lead the commercial efforts for the newly approved myoscience technology to treat wrinkles and pain.

Quentin is a highly accomplished Executive who brings 25 years of industry experience in Sales, Marketing, R&D and Strategy to the myoscience team. Most recently, Quentin successfully led the integration of Acclarent Inc. into ETHICON (J&J) across all functions. Prior to leading the integration, he was VP of EMEA Marketing at ETHICON where he built the regional marketing organization (>$1Bn business). He previously ran the ETHICON Products pipeline as an acting leader of R&D and was Director of Global Marketing for J&J Wound Management. Quentin started his career in sales and quickly became National Sales Director, AWC, J&J Medical. Throughout his career, he has launched more than twenty-two significant new products across diverse therapeutic areas and geographies. He holds an MBA from Warwick University Business School, UK and graduated with a BSc (honors) in Genetics from Leicester University.

Clint Carnell, CEO of myoscience, adds, "Quentin is a strong addition to the management team. We are delighted to add such a well-accomplished individual with deep sales and marketing experience to lead our European commercial launch.” About myoscience. Myoscience is a privately held medical device company dedicated to developing innovative treatments in whichever fields it chooses to enter. Two generations of the myoscience device have already been cleared for use by the FDA. www.myoscience.com


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->